Continuous and intermittent levamisole. A controlled trial.
A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.
Gorde:
| Argitaratua izan da: | Ann Rheum Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
1978
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1000218/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/356761/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.37.3.259 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|